Merit Medical Systems Inc
NASDAQ:MMSI

Watchlist Manager
Merit Medical Systems Inc Logo
Merit Medical Systems Inc
NASDAQ:MMSI
Watchlist
Price: 105.33 USD 0.29% Market Closed
Market Cap: 6.1B USD
Have any thoughts about
Merit Medical Systems Inc?
Write Note

Merit Medical Systems Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Merit Medical Systems Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Merit Medical Systems Inc
NASDAQ:MMSI
Other Long-Term Assets
$69.6m
CAGR 3-Years
15%
CAGR 5-Years
2%
CAGR 10-Years
15%
Haemonetics Corp
NYSE:HAE
Other Long-Term Assets
$164.8m
CAGR 3-Years
31%
CAGR 5-Years
37%
CAGR 10-Years
30%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Other Long-Term Assets
$263m
CAGR 3-Years
27%
CAGR 5-Years
23%
CAGR 10-Years
6%
ICU Medical Inc
NASDAQ:ICUI
Other Long-Term Assets
$121.3m
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
36%
Align Technology Inc
NASDAQ:ALGN
Other Long-Term Assets
$1.8B
CAGR 3-Years
4%
CAGR 5-Years
77%
CAGR 10-Years
52%
Lantheus Holdings Inc
NASDAQ:LNTH
Other Long-Term Assets
$151.5m
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
18%
No Stocks Found

Merit Medical Systems Inc
Glance View

Market Cap
6.1B USD
Industry
Health Care

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 6,446 full-time employees. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.

MMSI Intrinsic Value
87.16 USD
Overvaluation 17%
Intrinsic Value
Price

See Also

What is Merit Medical Systems Inc's Other Long-Term Assets?
Other Long-Term Assets
69.6m USD

Based on the financial report for Sep 30, 2024, Merit Medical Systems Inc's Other Long-Term Assets amounts to 69.6m USD.

What is Merit Medical Systems Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
15%

Over the last year, the Other Long-Term Assets growth was 27%. The average annual Other Long-Term Assets growth rates for Merit Medical Systems Inc have been 15% over the past three years , 2% over the past five years , and 15% over the past ten years .

Back to Top